盖莱克-3和可溶性CD146在严重烧伤患者中识别心脏病损伤:基于生物标志物的方法
Louis Boutin1,2,3, Sabri Soussi4,5, Angèle Garcia Lavello1
1Department of Anaesthesiology, Critical Care Medicine and Burn Unit, AP-HP, Saint-Louis Hospital, DMU Parabol, FHU PROMICE, Université de Paris, Paris, France.
Cardiorenal medicine
|August 12, 2024
概括
心脏病综合征 (CRS) 在严重烧伤患者中很常见. 加勒-3 (Gal3) 和可溶性CD146 (sCD146) 水平可以帮助识别CRS,它们的联合使用提高了预测准确性.
科学领域:
- 发现生物标志物的发现.
- 关键护理医学 关键护理医学
- 烧伤伤害研究研究
背景情况:
- 严重的烧伤伤害经常导致急性损伤 (AKI) 和心肌损伤 (MI).
- AKI和MI的组合,称为心脏脏综合征 (CRS),是一个重大的临床挑战.
- 识别不同的心脏内表型对于有效的患者管理至关重要.
研究的目的:
- 评估加勒-3 (Gal3) 和可溶性CD146 (sCD146) 的发生和可靠性,作为在严重烧伤患者中识别CRS的生物标志物.
- 评估这些生物标志物的预测性能,以识别CRS.
主要方法:
- 一个单一中心的前性概念验证研究.
- 在入院后7天内,每天收集血样本.
- CRS是由AKI (KDIGO阶段≥1) 和MI (升高的hsTnT) 的存在来定义的.
主要成果:
- 在40名患者中,有38名 (95%) 患有CRS.
- 单独或与sCD146相结合的Gal3水平与CRS显著相关 (p < 0.001).
- 在入院时,Gal3和sCD146的组合 (D0) 显示了对CRS的更好的预测性能 (AUC = 0.81).
- 3水平预测了没有MI的AKI和没有AKI的MI,而sCD146显示了与CRS的不良关联.
结论:
- CRS是严重烧伤患者的常见和严重并发症.
- 在入院后的第一周内,Gal3水平与CRS有关.
- 结合Gal3和sCD146可提高该患者群体中CRS的预测能力.
- 需要进一步的研究来确认这些生物标志物对CRS识别的有用性.
相关概念视频
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
121
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
121
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
69
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
69


